Cargando…

Clinical outcomes of COVID‐19 treated with remdesivir across the continuum of care

INTRODUCTION: During the early phase of the coronavirus disease 2019 (COVID‐19), remdesivir was only approved for hospitalized patients. Our institution developed hospital‐based, outpatient infusion centers for selected hospitalized patients with COVID‐19 who had clinical improvement to allow for ea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rivera, Christina G., Chesdachai, Supavit, Draper, Evan W., Arndt, Richard F., Mara, Kristin C., Gonzalez Suarez, Maria, Razonable, Raymund R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205088/ https://www.ncbi.nlm.nih.gov/pubmed/37228805 http://dx.doi.org/10.1111/irv.13136

Ejemplares similares

518. Comparable Outcomes of Remdesivir and Sotrovimab among High-risk Patients with Mild to Moderate COVID-19 During the Omicron BA.1 Surge
por: Chesdachai, Supavit, et al.
Publicado: (2023)

519. Early Transition to Outpatient Remdesivir Increases Patient Satisfaction while Decreasing Hospital Costs
por: Chesdachai, Supavit, et al.
Publicado: (2023)

Comparative renal risk of long-term use of beta-lactams in combination with vancomycin across the continuum of care
por: Dolly, Lauren M., et al.
Publicado: (2023)

2527. Impact of Hypoalbuminemia on Clinical Outcomes Among Patients with Obesity Treated with Ceftriaxone
por: Rivera (O'Connor), Christina G, et al.
Publicado: (2023)

The Effect of Infectious Diseases Consultation on Mortality in Hospitalized Patients With Methicillin-Resistant Staphylococcus aureus, Candida, and Pseudomonas Bloodstream Infections
por: Chesdachai, Supavit, et al.
Publicado: (2020)

Evidence for the 4Ms: Interactions and Outcomes across the Care Continuum
por: Mate, Kedar, et al.
Publicado: (2021)

Presentation, Management, and Outcomes Across the Rural-Urban Continuum for Hepatocellular Carcinoma
por: Zhou, Kali, et al.
Publicado: (2020)

Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus
por: Razonable, Raymund R.
Publicado: (2011)

Costs of Cancer Care Across the Disease Continuum
por: Kaye, Deborah R., et al.
Publicado: (2018)

Telemedicine across the continuum of neonatal-perinatal care
por: Chuo, John, et al.
Publicado: (2022)

92. Characteristics and Outcomes of Deep Brain Stimulation Device Related Infections: Experience from Quaternary Centers
por: Tabaja, Hussam, et al.
Publicado: (2021)

1779. Trends in Anaplasmosis Over the Past Decade: A Review of Clinical Features, Laboratory Data and Outcomes
por: Katragadda, Silpita, et al.
Publicado: (2023)

738. Outcomes of Ceftriaxone Versus Antistaphylococcal Penicillins or Cefazolin for Definitive Therapy of Methicillin-susceptible Staphylococcus aureus Bacteremia
por: Khodadadi, Ryan B, et al.
Publicado: (2022)

Efficacy and Safety of Direct-acting Antivirals in Hepatitis C Virus-infected Patients Taking Proton Pump Inhibitors
por: Wijarnpreecha, Karn, et al.
Publicado: (2017)

819. Experience with Isavuconazole Use for Treatment of Invasive Fungal Infections
por: Gow-Lee, Vanessa, et al.
Publicado: (2023)

THE MANY VOICES OF CARE PARTNERS ACROSS THE CONTINUUM OF CARE
por: Fox, Aimee, et al.
Publicado: (2022)

Virtual Care Across the Neonatal Intensive Care Continuum
por: Desai, Purnahamsi, et al.
Publicado: (2023)

445 Epidemiology and Outcomes of Clostridium difficile Infections in Heart and Heart-lung Transplant Recipients
por: Bruminhent, Jackrapong, et al.
Publicado: (2014)

Incidence and Outcomes of Bloodstream Infection After Arterial Aneurysm Repair: Findings From a Population-Based Study
por: Tabaja, Hussam, et al.
Publicado: (2023)

Clinical outcomes of remdesivir-treated COVID-19 patients in South Korea
por: Yu, Mi, et al.
Publicado: (2022)

Outcomes of B-Cell-Depleted Patients With Coronavirus Disease 2019 Treated With Antispike Monoclonal Antibodies
por: Yetmar, Zachary A, et al.
Publicado: (2022)

Defining Health Across the Cancer Continuum
por: Dulaney, Caleb, et al.
Publicado: (2017)

Cytomegalovirus Infections in Solid Organ Transplantation: A Review
por: Ramanan, Poornima, et al.
Publicado: (2013)

1565. Lymphocyte Subsets as Predictors of Cytomegalovirus Infection After Transplantation
por: Meesing, Atibordee, et al.
Publicado: (2018)

Absolute Lymphocyte Count Thresholds: A Simple, Readily Available Tool to Predict the Risk of Cytomegalovirus Infection After Transplantation
por: Meesing, Atibordee, et al.
Publicado: (2018)

COVID-19 and Solid Organ Transplantation: Role of Anti-SARS-CoV-2 Monoclonal Antibodies
por: Dhand, Abhay, et al.
Publicado: (2022)

Editorial: Neutralizing Antibodies in the Prevention and Treatment of COVID-19
por: Razonable, Raymund R., et al.
Publicado: (2022)

Technical Review of Clinical Outcomes Assessments Across the Continuum of Alzheimer's Disease
por: DiBenedetti, Dana B., et al.
Publicado: (2023)

Polygenic scoring accuracy varies across the genetic ancestry continuum
por: Ding, Yi, et al.
Publicado: (2023)

Cardiovascular device infections due to rapidly growing Mycobacteria: A review of cases at a tertiary care hospital
por: Comba, Isin Yagmur, et al.
Publicado: (2022)

Fusarium rhinosinusitis post chimeric antigen receptor T-cell therapy
por: Chesdachai, Supavit, et al.
Publicado: (2021)

2766. "A Retrospective Analysis of Non-Blood Sources of Achromobacter Infection and Antimicrobial Resistance Patterns: A Mayo Clinic Enterprise Experience"
por: Dumais, Mitchell, et al.
Publicado: (2023)

Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus
por: Melendez, Dante P, et al.
Publicado: (2015)

604 Risk Factors for Cytomegalovirus (CMV) Reactivation in CMV-seropositive Liver Transplant Patients
por: Bruminhent, Jackrapong, et al.
Publicado: (2014)

1536. Donor-Derived Mycobacterium tuberculosis Infection After Solid-Organ Transplantation: A Comprehensive Review
por: Abad, Cybele Lara, et al.
Publicado: (2018)

Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review
por: El Helou, Guy, et al.
Publicado: (2019)

Non-tuberculous mycobacterial infections in solid organ transplant recipients: An update
por: Abad, Cybele L., et al.
Publicado: (2016)

Stewardship of COVID-19 volunteers by nested trial design
por: Gottlieb, Robert L, et al.
Publicado: (2022)

Coronavirus Disease 2019 Management Strategies in Solid Organ Transplant Recipients
por: Mendoza, Maria Alejandra, et al.
Publicado: (2023)

Editorial: Brief interventions in suicide prevention across the continuum of care
por: Britton, Peter C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_or6637c373u90c6c0fhmr35m0h